Gemfibrozil

CAS No. 25812-30-0

Gemfibrozil( CI-719 | Lopid )

Catalog No. M13780 CAS No. 25812-30-0

Gemfibrozil (Lopid) is an oral drug used to lower lipid levels.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 27 In Stock
50MG 34 In Stock
100MG 45 In Stock
200MG 57 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Gemfibrozil
  • Note
    Research use only, not for human use.
  • Brief Description
    Gemfibrozil (Lopid) is an oral drug used to lower lipid levels.
  • Description
    Gemfibrozil (Lopid) is an oral drug used to lower lipid levels. It belongs to a group of drugs known as fibrates. Increases activity of Peroxisome proliferator-activated receptor-alpha (PPARα) 'transcription factor ligand' , a receptor that is involved in metabolism of carbohydrates and fats, as well as adipose tissue differentiation. This increase in the synthesis of lipoprotein lipase thereby increases the clearance of triglycerides.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CI-719 | Lopid
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    PPAR
  • Recptor
    PPARα
  • Research Area
    Metabolic Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    25812-30-0
  • Formula Weight
    250.33
  • Molecular Formula
    C15H22O3
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 50 mg/mL (199.73 mM); DMSO: 50 mg/mL (199.73 mM)
  • SMILES
    CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
  • Chemical Name
    5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Clavey V, et al. Cell Physiol Biochem. 1999;9(3):139-49.
molnova catalog
related products
  • Growth hormone relea...

    Growth hormone releasing peptide ia a natual product and has anti-inflammatory effects due to its inhibitory effect on PKC-induced activation of p38 JNK and NF-κB possibly by targeting to MKP-1 and PP2A.

  • Lonazolac

    Lonazolac is a nonsteroidal anti-inflammatory drug.

  • GW 501516

    A potent and subtype-selective PPARδ agonist with Ki of 1.1 nM in human PPARδ binding assay.